Cargando…

Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study

BACKGROUND: The Child–Turcotte–Pugh score (CTP) is the most commonly used tool to assess hepatic reserve and predict survival in hepatocellular cancer (HCC). The CTP stratification accuracy has been questioned and attempts have been made to improve the objectivity of the system. Serum insulin-like g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lacin, Sahin, Yalcin, Suayib, Karakas, Yusuf, Hassan, Manal M, Amin, Hesham, Mohamed, Yehia Ibrahim, Rashid, Asif, Morris, Jeffrey S, Xiao, Lianchun, Qayyum, Aliya, Kaseb, Ahmed O
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502406/ https://www.ncbi.nlm.nih.gov/pubmed/32984091 http://dx.doi.org/10.2147/JHC.S258930

Ejemplares similares

Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib
por: Mohamed, Yehia I., et al.
Publicado: (2021)

Metastatic medullary thyroid cancer: a dramatic response to a systemic chemotherapy (temozolomide and capecitabine) regimen
por: Lacin, Sahin, et al.
Publicado: (2015)

The Prognostic Value of Circulating VEGF-A Level in Patients With Hepatocellular Cancer
por: Lacin, Sahin, et al.
Publicado: (2020)

A case of acanthosis nigricans as a paraneoplastic syndrome with squamous cell lung cancer
por: Karakas, Yusuf, et al.
Publicado: (2016)

Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
por: Kaseb, Ahmed Omar, et al.
Publicado: (2016)

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients
por: Mohamed, Yehia I., et al.
Publicado: (2022)

Impact of tivozanib on patient outcomes in treatment of advanced renal cell carcinoma
por: Yalcin, Suayib, et al.
Publicado: (2019)

Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma
por: Pestana, Roberto Carmagnani, et al.
Publicado: (2018)

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?
por: Ali, Mahmoud A, et al.
Publicado: (2017)

Origin and role of hepatic myofibroblasts in hepatocellular carcinoma
por: Yavuz, Betul Gok, et al.
Publicado: (2020)

Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma
por: Kaseb, Ahmed O., et al.
Publicado: (2022)

Disruption of Growth Hormone Receptor Signaling Abrogates Hepatocellular Carcinoma Development
por: Haque, Abedul, et al.
Publicado: (2022)

Validation of an IGF-CTP scoring system for assessing hepatic reserve in egyptian patients with hepatocellular carcinoma
por: Abdel-Wahab, Reham, et al.
Publicado: (2015)

Development and Validation of Insulin-like Growth Factor-1 Score to Assess Hepatic Reserve in Hepatocellular Carcinoma
por: Kaseb, Ahmed O., et al.
Publicado: (2014)

Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma
por: Chamseddine, Shadi, et al.
Publicado: (2023)

Baseline Apparent Diffusion Coefficient as a Predictor of Response to Liver-Directed Therapies in Hepatocellular Carcinoma
por: Niekamp, Andrew, et al.
Publicado: (2018)

Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma
por: Abdel-Wahab, Reham, et al.
Publicado: (2015)

Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCC
por: Qayyum, Aliya, et al.
Publicado: (2019)

Artificial intelligence method to predict overall survival of hepatocellular carcinoma
por: Simsek, Cem, et al.
Publicado: (2021)

Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance
por: Khalaf, Ahmed M, et al.
Publicado: (2018)

Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma
por: Kaseb, Ahmed O, et al.
Publicado: (2016)

The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
por: Gok Yavuz, Betul, et al.
Publicado: (2023)

Type I insulin-like growth factor receptor signaling in hematological malignancies
por: Vishwamitra, Deeksha, et al.
Publicado: (2016)

Association of dietary fat intake and hepatocellular carcinoma among US adults
por: Moussa, Iman, et al.
Publicado: (2021)

A comment on ‘A morpho-molecular prognostic model for hepatocellular carcinoma'
por: Halil Sahin, I, et al.
Publicado: (2013)

Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells
por: Gu, Li, et al.
Publicado: (2023)

Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancer
por: Dandachi, Dima, et al.
Publicado: (2018)

Dietary Patterns and Hepatocellular Carcinoma Risk among US Adults
por: Moussa, Iman, et al.
Publicado: (2021)

A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by (90)Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma
por: Kaseb, Ahmed Omar, et al.
Publicado: (2021)

Lycopene sensitizes the cervical cancer cells to cisplatin via targeting nuclear factor-kappa B (NF-κB) pathway
por: AKTEPE, Oktay Halit, et al.
Publicado: (2021)

A review of the use of somatostatin analogs in oncology
por: Keskin, Ozge, et al.
Publicado: (2013)

Neuropathic cancer pain: What we are dealing with? How to manage it?
por: Esin, Ece, et al.
Publicado: (2014)

Recent Advances in Systemic Treatments for HER-2 Positive Advanced Gastric Cancer
por: Kahraman, Seda, et al.
Publicado: (2021)

Welcome to Journal of Hepatocellular Carcinoma
por: Kaseb, Ahmed O
Publicado: (2015)

Multimodality annotated hepatocellular carcinoma data set including pre- and post-TACE with imaging segmentation
por: Moawad, Ahmed W., et al.
Publicado: (2023)

Editorial: charting the future of hepatocellular carcinoma publications
por: Kaseb, Ahmed Omar
Publicado: (2018)

Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma
por: Gok Yavuz, Betul, et al.
Publicado: (2021)

Cardiac Arrest with Multi-vessel Coronary Artery Disease and Successful Treatment After Long Conventional Cardiopulmonary Resuscitation: How Long Is Too Long?
por: Nadeem, Rashid, et al.
Publicado: (2019)

Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors
por: Yıldız, Yetkin, et al.
Publicado: (2016)

Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience
por: Simsek, Cem, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fkdpat7rdbcrdtftes0gaho9ei